Neuronetics
STIM
55 hedge funds and large institutions have $20.9M invested in Neuronetics in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 17 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less funds holding
Funds holding: 59 → 55 (-4)
7.78% less ownership
Funds ownership: 65.51% → 57.73% (-7.8%)
10% less capital invested
Capital invested by funds: $23.1M → $20.9M (-$2.25M)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$606K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$319K |
| 3 |
DM
Deerfield Management
New York
|
+$243K |
| 4 |
PFM
Premier Fund Managers
Guildford,
United Kingdom
|
+$151K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.29M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$797K |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
-$526K |
| 4 |
State Street
Boston,
Massachusetts
|
-$438K |
| 5 |
JP Morgan Chase
New York
|
-$306K |
STIM Hedge Fund Activity: Q2 2020 in Review
55 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2020, worth a combined $20.9M — down 9.7% from $23.1M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of STIM and 13 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 13 added.
The largest buyer was Millrace Asset Group, opening a new position worth an estimated $606K. The largest seller was BlackRock, cutting an estimated $1.29M.
- 55 institutional investors held Neuronetics (STIM) as of Q2 2020, down from 59 in Q1 2020.
- Funds reported $20.9M of Neuronetics stock for Q2 2020, down 9.7% quarter-over-quarter.
- 13 funds opened new Neuronetics positions in Q2 2020 and 17 closed out, a net change of -4 holders.
- The largest Neuronetics buyer in Q2 2020 was Millrace Asset Group, an estimated $606K added.
- The largest Neuronetics seller in Q2 2020 was BlackRock, an estimated $1.29M sold.
Based on aggregated 13F filings for Q2 2020.